Amino acid and neuropeptide neurotransmitters in Huntington's disease cerebellum.
Several neuropathologic studies have suggested that there may be pathologic involvement of the cerebellum in Huntington's disease (HD). To investigate this further, we measured concentrations of neurotransmitter amino acids and the neuropeptides, somatostatin, neuropeptide Y and substance P, in HD cerebellar cortex and dentate nucleus. Twenty-seven pathologically confirmed cases of HD were compared with 20 controls. There were no significant changes in concentrations were significantly increased by 21% in HD cerebellar cortex. In the dentate nucleus, there were small significant increases of neuropeptide Y-like immunoreactivity and substance P-like immunoreactivity. The meaning of the neurotransmitter changes found is unclear: however, the lack of change in GABA and glutamate concentrations argues against a substantial loss of intrinsic cerebellar neurons.
Beal
M F
MF
Department of Neurology, Massachusetts General Hospital, Boston 02114.
Swartz
K J
KJ
Finn
S F
SF
Bird
E D
ED
Martin
J B
JB
D000368:Aged; D001224:Aspartic Acid / Q000378:metabolism*; D002531:Cerebellum / Q000378:metabolism*; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009478:Neuropeptide Y / Q000378:metabolism*; D009479:Neuropeptides / Q000378:metabolism*; D013004:Somatostatin / Q000378:metabolism; D013373:Substance P / Q000378:metabolism*
D009478:Neuropeptide Y; D009479:Neuropeptides; D001224:Aspartic Acid; D013373:Substance P; D013004:Somatostatin